United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $26.10 billion. The enterprise value is $22.56 billion.
| Market Cap | 26.10B |
| Enterprise Value | 22.56B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 42.89 million shares outstanding. The number of shares has decreased by -3.73% in one year.
| Current Share Class | 42.89M |
| Shares Outstanding | 42.89M |
| Shares Change (YoY) | -3.73% |
| Shares Change (QoQ) | -1.09% |
| Owned by Insiders (%) | 1.95% |
| Owned by Institutions (%) | 92.86% |
| Float | 39.21M |
Valuation Ratios
The trailing PE ratio is 22.94 and the forward PE ratio is 20.85. UTHR's PEG ratio is 3.16.
| PE Ratio | 22.94 |
| Forward PE | 20.85 |
| PS Ratio | 8.19 |
| Forward PS | 7.97 |
| PB Ratio | 4.11 |
| P/TBV Ratio | 4.24 |
| P/FCF Ratio | 30.10 |
| P/OCF Ratio | 18.26 |
| PEG Ratio | 3.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.65, with an EV/FCF ratio of 26.02.
| EV / Earnings | 18.33 |
| EV / Sales | 7.08 |
| EV / EBITDA | 15.65 |
| EV / EBIT | 16.77 |
| EV / FCF | 26.02 |
Financial Position
The company has a current ratio of 4.61, with zero debt.
| Current Ratio | 4.61 |
| Quick Ratio | 3.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 113.08 |
Financial Efficiency
Return on equity (ROE) is 19.13% and return on invested capital (ROIC) is 27.65%.
| Return on Equity (ROE) | 19.13% |
| Return on Assets (ROA) | 11.69% |
| Return on Invested Capital (ROIC) | 27.65% |
| Return on Capital Employed (ROCE) | 20.99% |
| Weighted Average Cost of Capital (WACC) | 6.89% |
| Revenue Per Employee | $2.28M |
| Profits Per Employee | $879,143 |
| Employee Count | 1,400 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.30 |
Taxes
In the past 12 months, UTHR has paid $277.00 million in taxes.
| Income Tax | 277.00M |
| Effective Tax Rate | 18.37% |
Stock Price Statistics
The stock price has increased by +38.72% in the last 52 weeks. The beta is 0.48, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +38.72% |
| 50-Day Moving Average | 532.33 |
| 200-Day Moving Average | 533.54 |
| Relative Strength Index (RSI) | 72.01 |
| Average Volume (20 Days) | 637,068 |
Short Selling Information
The latest short interest is 2.46 million, so 5.73% of the outstanding shares have been sold short.
| Short Interest | 2.46M |
| Short Previous Month | 3.60M |
| Short % of Shares Out | 5.73% |
| Short % of Float | 6.27% |
| Short Ratio (days to cover) | 2.42 |
Income Statement
In the last 12 months, UTHR had revenue of $3.19 billion and earned $1.23 billion in profits. Earnings per share was $26.53.
| Revenue | 3.19B |
| Gross Profit | 2.75B |
| Operating Income | 1.35B |
| Pretax Income | 1.51B |
| Net Income | 1.23B |
| EBITDA | 1.44B |
| EBIT | 1.35B |
| Earnings Per Share (EPS) | $26.53 |
Balance Sheet
The company has $2.07 billion in cash and no debt, with a net cash position of $3.54 billion or $82.44 per share.
| Cash & Cash Equivalents | 2.07B |
| Total Debt | n/a |
| Net Cash | 3.54B |
| Net Cash Per Share | $82.44 |
| Equity (Book Value) | 6.28B |
| Book Value Per Share | 148.08 |
| Working Capital | 2.26B |
Cash Flow
In the last 12 months, operating cash flow was $1.43 billion and capital expenditures -$562.40 million, giving a free cash flow of $867.20 million.
| Operating Cash Flow | 1.43B |
| Capital Expenditures | -562.40M |
| Depreciation & Amortization | 96.00M |
| Net Borrowing | n/a |
| Free Cash Flow | 867.20M |
| FCF Per Share | $20.22 |
Margins
Gross margin is 86.34%, with operating and profit margins of 42.22% and 38.61%.
| Gross Margin | 86.34% |
| Operating Margin | 42.22% |
| Pretax Margin | 47.30% |
| Profit Margin | 38.61% |
| EBITDA Margin | 45.23% |
| EBIT Margin | 42.22% |
| FCF Margin | 27.21% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.73% |
| Shareholder Yield | 3.73% |
| Earnings Yield | 4.36% |
| FCF Yield | 3.32% |
Analyst Forecast
The average price target for UTHR is $670.93, which is 10.26% higher than the current price. The consensus rating is "Buy".
| Price Target | $670.93 |
| Price Target Difference | 10.26% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 8.98% |
| EPS Growth Forecast (3Y) | 15.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |